다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Atara Biotherapeutics Inc (ATRA)
Atara Biotherapeutics Inc (ATRA) 뉴스

ATRA

Atara Biotherapeutics (ATRA)

Atara Biotherapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ATRA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/30	05:01	Business Wire	Atara Biotherapeutics Presents Preclinical Data on ATA3219, an Allogeneic CD19-Targeted CAR T Therapy for the Treatment of B-Cell Driven Autoimmune Diseases, at the ISCT 2024 Annual Meeting	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/23	07:18	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/21	09:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/21	09:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/21	09:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/21	09:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/21	09:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/20	22:25	Business Wire	Atara Biotherapeutics Submits Tabelecleucel (Tab-cel®) Biologics License Application for Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S. FDA	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/05/17	10:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc

검색 관련기사 보기:NASDAQ:ATRA

1 2 3 4 5 6 7 8 9 10 다음 >>

RSE Collection (GM)

FT Vest US Equity Deep B...

Staked Ice Tokens

BetaPro Crude Oil Invers... (CE)

Investec Bnk 23

Banco Santander

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관